| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.095 | 0.05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.089 | 0.07 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.063 | 0.2 |